GP Notify has been unable to send RPH admission, discharge or death notifications from 5th May 2018 due to technical issues. Please ensure all the GPs in your practice are aware that GP Notify is not currently sending. Other forms of communication, e.g. discharge summaries, are not affected.
Work is underway to resolve the issue as soon as possible. A system reset will need to be performed, which means that to receive GP Notifications in future, GPs will need to register. When you receive your GP Notify Confirmation form, please return it as soon as possible to ensure notifications restart.
Please accept our apologies for any incovenience.
A landmark in HIV prevention drugs, PrEP (tenofovir with emtricitabine) is now approved for use on the Pharmaceutical Benefits Scheme, thereby providing broader access for any doctor, general practitioner, and endorsed nurse practitioner to be able to prescribe PrEP to an eligible Austrlaian resident who holds a current Medicare card.
With funding from WA Health, ASHM will be providing a number of dinner updates in WA aimed at educating the health workforce to:
Further questions may be directed to Kate Bath (HIV Senior Project Officer) email@example.com or on 0413 471 937
The following advice has been communicated via Virus Watch dated 25th March 2018:
Four unrelated overseas-acquired cases have now been notified in WA residents over the past 10 days (two infected in Bali, one in Malaysia and the other most likely in Thailand or Malaysia).
People could potentially have been exposed to these cases at health-care facilities (including Bentley, Royal Perth and Joondalup Hospitals, GP surgeries, and pharmacies) and other sites around Perth.
Secondary cases might present up until around mid-April. Moreover, there may be an ongoing increased risk of measles infection in Bali at present.
It is recommended that measles vaccine be considered for people travelling overseas who were born after 1965 and who do not have documentation of having had two doses of measles vaccine.
Current and archived issues of Virus Watch http://ww2.health.wa.gov.au/Articles/F_I/Infectious-disease-data/Virus-WAtch
The 2018 edition of the guidelines combines Module 1 and 2 of the Antenatal Care Guidelines, published in 2012 and 2014 respectively. A number of chapters were reviewed and updated for this edition, in accordance with NHRMC requirements for guideline development.
The guidelines provide evidence based recommendations to support health professionals to provide high quality, safe antenatal care in all settings. They highlight specific approaches to pregnancy care for Aboriginal and Torres Strait Islander women, migrant and refugee women, and women with severe mental illness.
Among the changes is a new recommendation to encourage routine Hepatitis C testing at the first antenatal visit. Routine testing for Vitamin D status is now discouraged, unless there is a specific indication.
The guidelines recognise body mass index prior to pregnancy and weight gain during pregnancy as important determinants of health for both mothers and babies. The guidelines are designed for all health professionals caring for pregnant women, including midwives, obstetricians, general practitioners, Aboriginal and Torres Strait Islander health workers and allied health professionals.
The Pregnancy Care Guidelines can be downloaded here.
There have been a number of reports of severe euglycaemic ketoacidosis in patients with type 2 diabetes who are taking sodium-glucose co-transporter-2 inhibitors (SGLT2i) during the perioperative period. SGLT2i's are oral medications that promote glucose excretion in the urine for the treatment of type 2 diabetes.
Please read the alert here for further information about the symptoms and recommendations for practice.
Pathology Laboratories are reporting that a significant number of samples are being submitted from women under 25 years of age. Medicare does not fund routine HPV screening tests in women under 25 and testing of these samples will either need to be privately funded by the patient or, with the consent of the referring practitioner, not be processed.
Commencing screening at age 25 will reduce the investigation and treatment of common cervical abnormalities that would usually resolve by themselves. It can take 10 to 15 years for cervical cancer to develop from persistant HPV.
Women under 25 years who are currently under clinical management for a cervical abnormality should be managed according to the recommendations on transitioning individuals in the 2016 Guidelines.
Symptomatic women at any age
Women at any age who have signs or symptoms suggestive of cervical cancer (such as abnormal vaginal bleeding) should have a HPV and LBC co-test and be referred for the appropriate investigation to exclude genital tract malignancy.
Routine cervical screening is not recommended in women under the age of 25 years
However, for women who experienced early sexual activity at a young age (<14 years) and who had not received the HPV vaccine before sexual debut, or those that have been victims of sexual abuse, a single HPV test between 20 and 24 years of age could be considered on an individual basis.
To avoid out of pocket fees for your patients, please familiarise yourself with the Pathology Test Guide for Cervical and Vaginal Testing.
Further information on the Renewal of the National Cervical Screening Program is available at www.cancerscreening.gov.au/cervical
Virtual Visits give general practitioners more options to book NPS CPD at a date and time that suits them.
Virtual visits are interactive discussions or topic content and as such, they qualify for RACGP and ACRRM accreditation, typically;
The topics available are posted on the NPS website.
General practitioners and practice managers who would like to book an NPS Virtual Visit can book through the website or contact Nicole Humphry at WAPHA on 08 6272 4921 or email Nicole.Humphry@wapha.org.au.
A Notifiable Data Breach is a data breach that is likely to result in serious harm to any of the individuals to whom the information relates. A data breach occurs when personal information held by an organisation is lost or subjected to unauthorised access or disclosure.
Examples of a data breach include when:
The Privacy Amendment (Notifiable Data Breaches) Act 2017 established a Notifiable Data Breaches (NDB) scheme in Australia. The NDB scheme requires organisations covered by the Australian Privacy Act 1988 (Privacy Act) to notify any individuals likely to be at risk of serious harm by a data breach.
This includes ‘Health service providers’ which provide a health service and hold people’s health information. This generally includes general practitioners (GPs), pharmacists, therapists, allied health professionals, gyms and weight loss clinics, and childcare centres among others.
This notice must include recommendations about the steps that individuals should take in response to the data breach. The Australian Information Commissioner (Commissioner) must also be notified.
Organisations will need to be prepared to conduct quick assessments of suspected data breaches to determine if they are likely to result in serious harm.
The NDB scheme will commence on 22 February 2018. It only applies to eligible data breaches that occur on, or after, that date.
For more information and a range of resources, including templates for notifying individuals and the OAIC, visit the OAIC
Reasons for this change are:
The Alcohol and Drug Support Line offers a 24 hour helpline to patients who seek telephone counselling and advice in relation to alcohol and other drug issues:
(08) 9442 5000 or 1800 198 024 (country callers).
In Australia, over 75% of cancers first present in general practice as a result of symptoms. GPs play a key role in the early detection of cancer. GPs can experience challenges in early diagnosis as most GPs may only see between five to 10 new cases of cancer among thousands of consultations per year. Additionally, cancers in general practice often present with subtle non-specific symptoms and most symptoms of cancer can also have more common benign causes.
To assist GPs, Cancer Council Western Australia presents the Find Cancer Early GP Education Project with a new resource guide for GPs on colorectal, lung, prostate and breast cancer. The ‘Find Cancer Early: A Guide for General Practitioners’ resource provides evidence-based approaches to assess cancer symptoms to aid decision-making around further investigation or referral. The guide comes with a short video explaining how to use the guide in clinical practice and a WA Cancer Referral Directory. These resources are also accompanied with a Find Cancer Early Webinar Series. The series of four webinars host specialists presenting on; symptoms that best predict the four common cancers; implications for general practice when diagnosing patients with suspected cancer, and recommended referral pathways.
To access the resources and view the webinar recordings, visit www.cancerwa.asn.au/gp/fce.
This number is included in the revised patient handbook, which is being mailed to all Health Care Homes' practices and will be available online.
2-5/7 Tanunda Drive
Rivervale WA 6103